Major depressive disorder: Risk factors, characteristics and treatment options

Keyphrases

• Major Depressive Disorder 100%
• Risk Factors 100%
• Treatment Options 100%
• Treatment-resistant Depression 100%
• Risk Characteristics 100%
• Risk Treatment 100%
• Genetic Susceptibility 66%
• Biological Characteristics 66%
• Clinical Features 33%
• Neurotransmitters 33%
• Functional Magnetic Resonance Imaging 33%
• Structural Magnetic Resonance Imaging (sMRI) 33%
• Clinical Characteristics 33%
• Homeostatic Regulation 33%
• Inflammation 33%
• Clinical Symptoms 33%
• Neurodegeneration 33%
• Neurogenesis 33%
• Dysregulation 33%
• Pharmacologic Targets 33%
• Depression Treatment 33%
• Biological Treatment 33%
• Neuroinflammation 33%
• Mood Disorders 33%
• Neurobiology 33%
• Novae 33%
• Genetic Markers 33%
• Neuromodulation 33%
• Psychosocial Environment 33%
• Hypothesis-driven 33%
• Neurodevelopment 33%
• Promising Treatment 33%
• Serum Markers 33%
• Neuroimaging Markers 33%
• Treatment Response Prediction 33%
• Treatment for Depression 33%
• Neurotrophic Hypothesis 33%
• MRI Markers 33%
• Biopsychosocial Factors 33%
• Susceptibility-weighted Imaging 33%
• BDNF-TrkB Signaling 33%
• Neurogenetics 33%
• Psychosocial Context 33%
• Clinical Heterogeneity 33%

Pharmacology, Toxicology and Pharmaceutical Science

• Major Depression 100%
• Treatment Resistant Depression 100%
• Biological Marker 66%
• Genetic Susceptibility 66%
• Neurotransmitter 33%
• Inflammation 33%
• Nerve Degeneration 33%
• Nervous System Inflammation 33%
• Brain Derived Neurotrophic Factor 33%
• Mood Disorder 33%

Neuroscience

• Major Depressive Disorder 100%
• Treatment-Resistant Depression 100%
• Neurotransmitter 33%
• Cell Signaling 33%
• Functional Magnetic Resonance Imaging 33%
• Brain-Derived Neurotrophic Factor 33%
• Neurodegeneration 33%
• Neurogenesis 33%
• Nerve Cell Differentiation 33%
• Mood Disorder 33%
• Neuromodulation 33%
• Neurobiology 33%